nodes	percent_of_prediction	percent_of_DWPC	metapath
Difluprednate—NR3C1—Transcription factor regulation in adipogenesis—TWIST1—stomach cancer	0.0415	0.0643	CbGpPWpGaD
Difluprednate—Amcinonide—ANXA1—stomach cancer	0.0382	0.62	CrCbGaD
Difluprednate—NR3C1—FOXA2 and FOXA3 transcription factor networks—AFP—stomach cancer	0.028	0.0434	CbGpPWpGaD
Difluprednate—Lacrimation increased—Floxuridine—stomach cancer	0.0251	0.0856	CcSEcCtD
Difluprednate—Scab—Fluorouracil—stomach cancer	0.0237	0.081	CcSEcCtD
Difluprednate—NR3C1—Nuclear Receptors—RXRB—stomach cancer	0.0218	0.0338	CbGpPWpGaD
Difluprednate—Photophobia—Floxuridine—stomach cancer	0.0217	0.074	CcSEcCtD
Difluprednate—Punctate keratitis—Capecitabine—stomach cancer	0.0208	0.0712	CcSEcCtD
Difluprednate—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—RORA—stomach cancer	0.0181	0.028	CbGpPWpGaD
Difluprednate—NR3C1—Nuclear Receptors—RORA—stomach cancer	0.0177	0.0274	CbGpPWpGaD
Difluprednate—NR3C1—Nuclear Receptor transcription pathway—RXRB—stomach cancer	0.0173	0.0267	CbGpPWpGaD
Difluprednate—NR3C1—Glucocorticoid receptor regulatory network—AFP—stomach cancer	0.017	0.0264	CbGpPWpGaD
Difluprednate—NR3C1—Regulation of Androgen receptor activity—RXRB—stomach cancer	0.0167	0.0259	CbGpPWpGaD
Difluprednate—Scab—Capecitabine—stomach cancer	0.0166	0.0566	CcSEcCtD
Difluprednate—NR3C1—Nuclear Receptors—RARB—stomach cancer	0.0158	0.0245	CbGpPWpGaD
Difluprednate—NR3C1—FOXA2 and FOXA3 transcription factor networks—ALDOB—stomach cancer	0.0147	0.0228	CbGpPWpGaD
Difluprednate—NR3C1—Nuclear Receptor transcription pathway—RORA—stomach cancer	0.014	0.0216	CbGpPWpGaD
Difluprednate—NR3C1—Adipogenesis—KLF6—stomach cancer	0.0132	0.0205	CbGpPWpGaD
Difluprednate—NR3C1—Circadian Clock—RORA—stomach cancer	0.0131	0.0204	CbGpPWpGaD
Difluprednate—NR3C1—AP-1 transcription factor network—MT2A—stomach cancer	0.0131	0.0204	CbGpPWpGaD
Difluprednate—NR3C1—Nuclear Receptor transcription pathway—RARB—stomach cancer	0.0125	0.0193	CbGpPWpGaD
Difluprednate—Blepharitis—Fluorouracil—stomach cancer	0.0122	0.0418	CcSEcCtD
Difluprednate—Dexamethasone—ANXA1—stomach cancer	0.012	0.195	CrCbGaD
Difluprednate—NR3C1—Endoderm Differentiation—BMP7—stomach cancer	0.0117	0.0181	CbGpPWpGaD
Difluprednate—NR3C1—Transcription factor regulation in adipogenesis—IRS2—stomach cancer	0.0111	0.0172	CbGpPWpGaD
Difluprednate—NR3C1—Adipogenesis—TWIST1—stomach cancer	0.01	0.0155	CbGpPWpGaD
Difluprednate—NR3C1—Transcription factor regulation in adipogenesis—PPARG—stomach cancer	0.00947	0.0147	CbGpPWpGaD
Difluprednate—NR3C1—Regulation of nuclear SMAD2/3 signaling—RUNX3—stomach cancer	0.00943	0.0146	CbGpPWpGaD
Difluprednate—NR3C1—Adipogenesis—PLIN2—stomach cancer	0.00942	0.0146	CbGpPWpGaD
Difluprednate—NR3C1—Glucocorticoid receptor regulatory network—FGG—stomach cancer	0.00895	0.0139	CbGpPWpGaD
Difluprednate—Visual acuity reduced—Capecitabine—stomach cancer	0.00885	0.0302	CcSEcCtD
Difluprednate—Eye irritation—Fluorouracil—stomach cancer	0.00882	0.0301	CcSEcCtD
Difluprednate—Lacrimation increased—Irinotecan—stomach cancer	0.00854	0.0292	CcSEcCtD
Difluprednate—Lacrimation increased—Fluorouracil—stomach cancer	0.00818	0.0279	CcSEcCtD
Difluprednate—Herpes simplex—Fluorouracil—stomach cancer	0.00818	0.0279	CcSEcCtD
Difluprednate—NR3C1—Generic Transcription Pathway—ZNF559—stomach cancer	0.00749	0.0116	CbGpPWpGaD
Difluprednate—Vision blurred—Mitomycin—stomach cancer	0.00746	0.0255	CcSEcCtD
Difluprednate—Photophobia—Fluorouracil—stomach cancer	0.00707	0.0242	CcSEcCtD
Difluprednate—NR3C1—Glucocorticoid receptor regulatory network—IRF1—stomach cancer	0.00692	0.0107	CbGpPWpGaD
Difluprednate—NR3C1—Regulation of nuclear SMAD2/3 signaling—HSPA8—stomach cancer	0.00662	0.0103	CbGpPWpGaD
Difluprednate—NR3C1—Adipogenesis—RORA—stomach cancer	0.00661	0.0102	CbGpPWpGaD
Difluprednate—Eye irritation—Docetaxel—stomach cancer	0.00637	0.0218	CcSEcCtD
Difluprednate—NR3C1—Transcription factor regulation in adipogenesis—MAPK8—stomach cancer	0.00635	0.00984	CbGpPWpGaD
Difluprednate—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—MAPK3—stomach cancer	0.00624	0.00966	CbGpPWpGaD
Difluprednate—NR3C1—FOXA2 and FOXA3 transcription factor networks—APOA1—stomach cancer	0.00617	0.00956	CbGpPWpGaD
Difluprednate—Eye irritation—Capecitabine—stomach cancer	0.00617	0.0211	CcSEcCtD
Difluprednate—NR3C1—Nuclear Receptors—PPARG—stomach cancer	0.00611	0.00947	CbGpPWpGaD
Difluprednate—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—MAPK1—stomach cancer	0.00594	0.0092	CbGpPWpGaD
Difluprednate—NR3C1—Adipogenesis—AHR—stomach cancer	0.00591	0.00915	CbGpPWpGaD
Difluprednate—Lacrimation increased—Docetaxel—stomach cancer	0.0059	0.0202	CcSEcCtD
Difluprednate—Lacrimation increased—Capecitabine—stomach cancer	0.00571	0.0195	CcSEcCtD
Difluprednate—Herpes simplex—Capecitabine—stomach cancer	0.00571	0.0195	CcSEcCtD
Difluprednate—NR3C1—SIDS Susceptibility Pathways—RORA—stomach cancer	0.00571	0.00884	CbGpPWpGaD
Difluprednate—NR3C1—Generic Transcription Pathway—ZNF160—stomach cancer	0.00568	0.00879	CbGpPWpGaD
Difluprednate—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—SERPINE1—stomach cancer	0.00563	0.00871	CbGpPWpGaD
Difluprednate—NR3C1—SIDS Susceptibility Pathways—RUNX3—stomach cancer	0.00558	0.00864	CbGpPWpGaD
Difluprednate—NR3C1—Endoderm Differentiation—SMAD4—stomach cancer	0.00552	0.00854	CbGpPWpGaD
Difluprednate—NR3C1—SIDS Susceptibility Pathways—HSPD1—stomach cancer	0.00525	0.00813	CbGpPWpGaD
Difluprednate—NR3C1—AP-1 transcription factor network—IL10—stomach cancer	0.00523	0.0081	CbGpPWpGaD
Difluprednate—Headache—Floxuridine—stomach cancer	0.00516	0.0176	CcSEcCtD
Difluprednate—NR3C1—Transcription factor regulation in adipogenesis—TNF—stomach cancer	0.00503	0.00779	CbGpPWpGaD
Difluprednate—NR3C1—Adipogenesis—BMP2—stomach cancer	0.00489	0.00758	CbGpPWpGaD
Difluprednate—NR3C1—FOXA2 and FOXA3 transcription factor networks—ALB—stomach cancer	0.00489	0.00757	CbGpPWpGaD
Difluprednate—Dry eye—Capecitabine—stomach cancer	0.00486	0.0166	CcSEcCtD
Difluprednate—NR3C1—Nuclear Receptor transcription pathway—PPARG—stomach cancer	0.00483	0.00748	CbGpPWpGaD
Difluprednate—NR3C1—Regulation of nuclear SMAD2/3 signaling—SMAD4—stomach cancer	0.0048	0.00743	CbGpPWpGaD
Difluprednate—NR3C1—Regulation of nuclear SMAD2/3 signaling—IL10—stomach cancer	0.00466	0.00721	CbGpPWpGaD
Difluprednate—NR3C1—Adipogenesis—GADD45A—stomach cancer	0.00438	0.00678	CbGpPWpGaD
Difluprednate—NR3C1—AP-1 transcription factor network—PLAU—stomach cancer	0.00437	0.00676	CbGpPWpGaD
Difluprednate—Herpes simplex—Methotrexate—stomach cancer	0.00425	0.0145	CcSEcCtD
Difluprednate—Eye pain—Capecitabine—stomach cancer	0.00423	0.0145	CcSEcCtD
Difluprednate—NR3C1—SIDS Susceptibility Pathways—HTR1A—stomach cancer	0.00412	0.00638	CbGpPWpGaD
Difluprednate—NR3C1—Circadian Clock—SERPINE1—stomach cancer	0.0041	0.00635	CbGpPWpGaD
Difluprednate—NR3C1—Transcription factor regulation in adipogenesis—IL6—stomach cancer	0.00406	0.00628	CbGpPWpGaD
Difluprednate—Headache—Mitomycin—stomach cancer	0.00405	0.0138	CcSEcCtD
Difluprednate—Lacrimation increased—Epirubicin—stomach cancer	0.00398	0.0136	CcSEcCtD
Difluprednate—Herpes simplex—Epirubicin—stomach cancer	0.00398	0.0136	CcSEcCtD
Difluprednate—NR3C1—Endoderm Differentiation—APC—stomach cancer	0.00398	0.00616	CbGpPWpGaD
Difluprednate—NR3C1—SIDS Susceptibility Pathways—IL1RN—stomach cancer	0.00385	0.00596	CbGpPWpGaD
Difluprednate—Dexamethasone—CYP2A6—stomach cancer	0.00369	0.0597	CrCbGaD
Difluprednate—Herpes simplex—Doxorubicin—stomach cancer	0.00368	0.0126	CcSEcCtD
Difluprednate—Lacrimation increased—Doxorubicin—stomach cancer	0.00368	0.0126	CcSEcCtD
Difluprednate—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDK4—stomach cancer	0.00367	0.00569	CbGpPWpGaD
Difluprednate—NR3C1—Gene Expression—ZNF559—stomach cancer	0.00361	0.00559	CbGpPWpGaD
Difluprednate—Dry eye—Epirubicin—stomach cancer	0.00339	0.0116	CcSEcCtD
Difluprednate—Triamcinolone—PTGS2—stomach cancer	0.00339	0.0549	CrCbGaD
Difluprednate—NR3C1—Regulation of Androgen receptor activity—JUN—stomach cancer	0.00332	0.00515	CbGpPWpGaD
Difluprednate—NR3C1—AP-1 transcription factor network—CDKN2A—stomach cancer	0.00315	0.00489	CbGpPWpGaD
Difluprednate—NR3C1—Regulation of Androgen receptor activity—MAPK8—stomach cancer	0.00314	0.00487	CbGpPWpGaD
Difluprednate—Dry eye—Doxorubicin—stomach cancer	0.00313	0.0107	CcSEcCtD
Difluprednate—Weight increased—Docetaxel—stomach cancer	0.00311	0.0106	CcSEcCtD
Difluprednate—Vision blurred—Fluorouracil—stomach cancer	0.0031	0.0106	CcSEcCtD
Difluprednate—NR3C1—Gene Expression—PRPF19—stomach cancer	0.00307	0.00475	CbGpPWpGaD
Difluprednate—Weight increased—Capecitabine—stomach cancer	0.00301	0.0103	CcSEcCtD
Difluprednate—NR3C1—Regulation of nuclear SMAD2/3 signaling—SERPINE1—stomach cancer	0.00301	0.00466	CbGpPWpGaD
Difluprednate—NR3C1—Generic Transcription Pathway—RXRB—stomach cancer	0.00298	0.00462	CbGpPWpGaD
Difluprednate—Eye pain—Epirubicin—stomach cancer	0.00295	0.0101	CcSEcCtD
Difluprednate—NR3C1—SIDS Susceptibility Pathways—BDNF—stomach cancer	0.00289	0.00447	CbGpPWpGaD
Difluprednate—NR3C1—AP-1 transcription factor network—CXCL8—stomach cancer	0.00286	0.00443	CbGpPWpGaD
Difluprednate—NR3C1—AP-1 transcription factor network—CDKN1B—stomach cancer	0.00279	0.00433	CbGpPWpGaD
Difluprednate—Betamethasone—PTGS2—stomach cancer	0.00277	0.045	CrCbGaD
Difluprednate—NR3C1—SIDS Susceptibility Pathways—IL10—stomach cancer	0.00276	0.00427	CbGpPWpGaD
Difluprednate—NR3C1—Gene Expression—ZNF160—stomach cancer	0.00273	0.00423	CbGpPWpGaD
Difluprednate—Eye pain—Doxorubicin—stomach cancer	0.00273	0.00932	CcSEcCtD
Difluprednate—NR3C1—Adipogenesis—IRS2—stomach cancer	0.00268	0.00415	CbGpPWpGaD
Difluprednate—NR3C1—AP-1 transcription factor network—CCND1—stomach cancer	0.00267	0.00413	CbGpPWpGaD
Difluprednate—NR3C1—AP-1 transcription factor network—JUN—stomach cancer	0.00266	0.00412	CbGpPWpGaD
Difluprednate—NR3C1—AP-1 transcription factor network—MMP9—stomach cancer	0.00259	0.00401	CbGpPWpGaD
Difluprednate—NR3C1—Glucocorticoid receptor regulatory network—CXCL8—stomach cancer	0.00252	0.0039	CbGpPWpGaD
Difluprednate—NR3C1—Gene Expression—EEF1A2—stomach cancer	0.0025	0.00387	CbGpPWpGaD
Difluprednate—NR3C1—Adipogenesis—IL6ST—stomach cancer	0.00246	0.00382	CbGpPWpGaD
Difluprednate—NR3C1—Generic Transcription Pathway—RORA—stomach cancer	0.00241	0.00374	CbGpPWpGaD
Difluprednate—NR3C1—Regulation of nuclear SMAD2/3 signaling—JUN—stomach cancer	0.00237	0.00367	CbGpPWpGaD
Difluprednate—NR3C1—Glucocorticoid receptor regulatory network—JUN—stomach cancer	0.00234	0.00363	CbGpPWpGaD
Difluprednate—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDKN1A—stomach cancer	0.00229	0.00355	CbGpPWpGaD
Difluprednate—NR3C1—Adipogenesis—PPARG—stomach cancer	0.00229	0.00354	CbGpPWpGaD
Difluprednate—NR3C1—Glucocorticoid receptor regulatory network—CDKN1A—stomach cancer	0.00227	0.00352	CbGpPWpGaD
Difluprednate—NR3C1—Glucocorticoid receptor regulatory network—MAPK8—stomach cancer	0.00222	0.00343	CbGpPWpGaD
Difluprednate—Vision blurred—Capecitabine—stomach cancer	0.00217	0.00741	CcSEcCtD
Difluprednate—NR3C1—Generic Transcription Pathway—RARB—stomach cancer	0.00216	0.00334	CbGpPWpGaD
Difluprednate—NR3C1—AP-1 transcription factor network—MYC—stomach cancer	0.00214	0.00331	CbGpPWpGaD
Difluprednate—Weight increased—Epirubicin—stomach cancer	0.00209	0.00716	CcSEcCtD
Difluprednate—NR3C1—Gene Expression—HNRNPL—stomach cancer	0.00207	0.00321	CbGpPWpGaD
Difluprednate—NR3C1—Adipogenesis—SERPINE1—stomach cancer	0.00206	0.00319	CbGpPWpGaD
Difluprednate—NR3C1—Gene Expression—EEF1A1—stomach cancer	0.00198	0.00306	CbGpPWpGaD
Difluprednate—Weight increased—Doxorubicin—stomach cancer	0.00194	0.00662	CcSEcCtD
Difluprednate—NR3C1—Glucocorticoid receptor regulatory network—MAPK3—stomach cancer	0.00194	0.003	CbGpPWpGaD
Difluprednate—NR3C1—Regulation of nuclear SMAD2/3 signaling—MYC—stomach cancer	0.0019	0.00295	CbGpPWpGaD
Difluprednate—Pruritus—Fluorouracil—stomach cancer	0.0019	0.0065	CcSEcCtD
Difluprednate—NR3C1—SIDS Susceptibility Pathways—IL6R—stomach cancer	0.0019	0.00294	CbGpPWpGaD
Difluprednate—NR3C1—Glucocorticoid receptor regulatory network—MAPK1—stomach cancer	0.00184	0.00285	CbGpPWpGaD
Difluprednate—Headache—Irinotecan—stomach cancer	0.00176	0.00601	CcSEcCtD
Difluprednate—NR3C1—AP-1 transcription factor network—TP53—stomach cancer	0.00176	0.00272	CbGpPWpGaD
Difluprednate—NR3C1—Gene Expression—CPSF1—stomach cancer	0.00171	0.00264	CbGpPWpGaD
Difluprednate—NR3C1—Gene Expression—EXOSC5—stomach cancer	0.00171	0.00264	CbGpPWpGaD
Difluprednate—Headache—Fluorouracil—stomach cancer	0.00168	0.00575	CcSEcCtD
Difluprednate—NR3C1—Gene Expression—POLR3K—stomach cancer	0.00166	0.00257	CbGpPWpGaD
Difluprednate—Vision blurred—Methotrexate—stomach cancer	0.00161	0.00552	CcSEcCtD
Difluprednate—Dexamethasone—PTGS2—stomach cancer	0.00161	0.0262	CrCbGaD
Difluprednate—NR3C1—AP-1 transcription factor network—IL6—stomach cancer	0.00161	0.00249	CbGpPWpGaD
Difluprednate—NR3C1—Adipogenesis—CDKN1A—stomach cancer	0.00157	0.00243	CbGpPWpGaD
Difluprednate—NR3C1—Glucocorticoid receptor regulatory network—TP53—stomach cancer	0.00155	0.0024	CbGpPWpGaD
Difluprednate—Vision blurred—Epirubicin—stomach cancer	0.00151	0.00516	CcSEcCtD
Difluprednate—NR3C1—SIDS Susceptibility Pathways—CXCL8—stomach cancer	0.00151	0.00233	CbGpPWpGaD
Difluprednate—NR3C1—SIDS Susceptibility Pathways—IL1B—stomach cancer	0.00145	0.00224	CbGpPWpGaD
Difluprednate—NR3C1—Gene Expression—RXRB—stomach cancer	0.00144	0.00222	CbGpPWpGaD
Difluprednate—NR3C1—Glucocorticoid receptor regulatory network—IL6—stomach cancer	0.00142	0.00219	CbGpPWpGaD
Difluprednate—NR3C1—Gene Expression—RPL13—stomach cancer	0.00141	0.00218	CbGpPWpGaD
Difluprednate—NR3C1—Gene Expression—RPL18—stomach cancer	0.00141	0.00218	CbGpPWpGaD
Difluprednate—NR3C1—Adipogenesis—STAT3—stomach cancer	0.0014	0.00217	CbGpPWpGaD
Difluprednate—NR3C1—SIDS Susceptibility Pathways—JUN—stomach cancer	0.0014	0.00217	CbGpPWpGaD
Difluprednate—Vision blurred—Doxorubicin—stomach cancer	0.0014	0.00478	CcSEcCtD
Difluprednate—Pruritus—Docetaxel—stomach cancer	0.00137	0.00469	CcSEcCtD
Difluprednate—Pruritus—Capecitabine—stomach cancer	0.00133	0.00454	CcSEcCtD
Difluprednate—NR3C1—Gene Expression—RPS15—stomach cancer	0.00131	0.00203	CbGpPWpGaD
Difluprednate—NR3C1—Gene Expression—RPS21—stomach cancer	0.00131	0.00203	CbGpPWpGaD
Difluprednate—NR3C1—Gene Expression—SNRPB—stomach cancer	0.00129	0.002	CbGpPWpGaD
Difluprednate—NR3C1—SIDS Susceptibility Pathways—VEGFA—stomach cancer	0.00122	0.0019	CbGpPWpGaD
Difluprednate—Headache—Docetaxel—stomach cancer	0.00122	0.00415	CcSEcCtD
Difluprednate—NR3C1—Adipogenesis—TNF—stomach cancer	0.00121	0.00188	CbGpPWpGaD
Difluprednate—NR3C1—Generic Transcription Pathway—SMAD4—stomach cancer	0.0012	0.00186	CbGpPWpGaD
Difluprednate—Headache—Capecitabine—stomach cancer	0.00118	0.00402	CcSEcCtD
Difluprednate—NR3C1—Gene Expression—RORA—stomach cancer	0.00116	0.0018	CbGpPWpGaD
Difluprednate—NR3C1—Gene Expression—DNMT3B—stomach cancer	0.00109	0.00169	CbGpPWpGaD
Difluprednate—NR3C1—Gene Expression—RPL15—stomach cancer	0.00107	0.00165	CbGpPWpGaD
Difluprednate—NR3C1—SIDS Susceptibility Pathways—TNF—stomach cancer	0.00105	0.00162	CbGpPWpGaD
Difluprednate—NR3C1—Gene Expression—RARB—stomach cancer	0.00104	0.00161	CbGpPWpGaD
Difluprednate—NR3C1—Gene Expression—RPS26—stomach cancer	0.000995	0.00154	CbGpPWpGaD
Difluprednate—Pruritus—Methotrexate—stomach cancer	0.000989	0.00338	CcSEcCtD
Difluprednate—NR3C1—Adipogenesis—IL6—stomach cancer	0.000979	0.00152	CbGpPWpGaD
Difluprednate—Pruritus—Epirubicin—stomach cancer	0.000926	0.00316	CcSEcCtD
Difluprednate—Headache—Methotrexate—stomach cancer	0.000876	0.00299	CcSEcCtD
Difluprednate—NR3C1—Gene Expression—HSPB1—stomach cancer	0.00087	0.00135	CbGpPWpGaD
Difluprednate—Pruritus—Doxorubicin—stomach cancer	0.000857	0.00293	CcSEcCtD
Difluprednate—NR3C1—SIDS Susceptibility Pathways—IL6—stomach cancer	0.000846	0.00131	CbGpPWpGaD
Difluprednate—NR3C1—Gene Expression—RPS19—stomach cancer	0.000846	0.00131	CbGpPWpGaD
Difluprednate—NR3C1—Generic Transcription Pathway—PPARG—stomach cancer	0.000834	0.00129	CbGpPWpGaD
Difluprednate—Headache—Epirubicin—stomach cancer	0.00082	0.0028	CcSEcCtD
Difluprednate—NR3C1—Gene Expression—DNMT1—stomach cancer	0.000809	0.00125	CbGpPWpGaD
Difluprednate—NR3C1—Gene Expression—HSPA8—stomach cancer	0.000797	0.00124	CbGpPWpGaD
Difluprednate—Headache—Doxorubicin—stomach cancer	0.000759	0.00259	CcSEcCtD
Difluprednate—NR3C1—Generic Transcription Pathway—SERPINE1—stomach cancer	0.000752	0.00116	CbGpPWpGaD
Difluprednate—NR3C1—Gene Expression—RPS6—stomach cancer	0.000748	0.00116	CbGpPWpGaD
Difluprednate—NR3C1—Gene Expression—PPP2R1A—stomach cancer	0.000622	0.000963	CbGpPWpGaD
Difluprednate—NR3C1—Gene Expression—SMAD4—stomach cancer	0.000577	0.000894	CbGpPWpGaD
Difluprednate—NR3C1—Gene Expression—ERCC2—stomach cancer	0.000527	0.000816	CbGpPWpGaD
Difluprednate—NR3C1—Generic Transcription Pathway—MYC—stomach cancer	0.000476	0.000737	CbGpPWpGaD
Difluprednate—NR3C1—Gene Expression—PPARG—stomach cancer	0.000402	0.000622	CbGpPWpGaD
Difluprednate—NR3C1—Gene Expression—SERPINE1—stomach cancer	0.000362	0.000561	CbGpPWpGaD
Difluprednate—NR3C1—Gene Expression—MAPK3—stomach cancer	0.000235	0.000365	CbGpPWpGaD
Difluprednate—NR3C1—Gene Expression—MYC—stomach cancer	0.000229	0.000355	CbGpPWpGaD
